WuXi Biologics and Inhibrx, Inc. have entered into an exclusive partnership for the GMP manufacture of certain Inhibrx’s protein-based therapeutics. Inhibrx use WuXi Biologics for GMP manufacturing of its human biologic therapeutics for all projects to be initiated within next three years, during which Inhibrx plans to initiate clinical trials outside of China. “We have a very strong working relationship with WuXi Biologics. Over the last two years, WuXi Biologics has executed ...